Januvia 100 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB26FATZV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,455
Award facts
- Contract value 100% obligated
- $1,455.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,455.28 to DMS Pharmaceutical Group Inc. for 90 tablets of Januvia 100 mg, a diabetes medication. The delivery order, issued on October 29, 2025, with an ultimate completion date of October 30, 2025, represents a routine pharmaceutical supply transaction under the agency's Medical Supply Chain operations. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its Conshohocken, Pennsylvania facility. No set-aside designation was used in this award.
This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.9 billion master contract awarded on November 13, 2025. The PPV-G GEN V represents the broader $30.3 billion Defense Logistics Agency acquisition strategy designed to establish multiple regional prime vendor contractors supplying pharmaceuticals, biologics, and medical consumables to support Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance on numerous delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system across multiple therapeutic categories.
Quick answers
Who was awarded contract SPE2DB26FATZV?
SPE2DB26FATZV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FATZV worth?
The government has obligated $1,455 on SPE2DB26FATZV.
Is contract SPE2DB26FATZV an order under another contract?
Yes. SPE2DB26FATZV is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB26FATZV competed?
The extent of competition for SPE2DB26FATZV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award